Concepedia

David E. Lawhorn

DE

Statistics

Publications

4

Citations

176

H-Index

4

Active since

1990

Affiliations

Eli Lilly (United States)(Current)

David E. Lawhorn is an author at Eli Lilly (United States) specializing in enzyme inhibition, steroid pharmacology, and medicinal chemistry.

Publications per year

1990–1993

4

Publications

4

Nonsteroidal inhibitors of human type I steroid 5-.alpha.-reductase

Charles D. Jones, James E. Audia, David E. Lawhorn et al. · Journal of Medicinal Chemistry · 1993 · 90 citations · Full text

, , +10

Regio- and stereochemical course of the ring expansion of bridged bicyclic ketones to spirocyclic .alpha.-keto tetrahydrofurans.

Leo A. Paquette, John Andrews, Corinne Vanucci et al. · The Journal of Organic Chemistry · 1992 · 35 citations

, , +9

Response of 2-Lithio-4,5-dihydrofuran — Ketone Adducts to Acid Catalysis

Leo A. Paquette, David E. Lawhorn, Christopher A. Teleha · Heterocycles · 1990 · 26 citations · Full text

, , +10

Synthesis of the individual enantiomers of the benzoquinolinone human type 1 steroid 5-α-reductase inhibitors LY191704 and LY266111

James E. Audia, David E. Lawhorn, Jack B. Deeter · Tetrahedron Letters · 1993 · 25 citations

, , +12

1–4 of 4